|
Market Cap (20-May) $4,758,880 (1,313th) |
Close (30-Jun) $1.51 |
Volume (30-Jun) 12,937 |
Shortsold (8-Aug) 2,108 (0.02%) (508th) |
|
52w High $1.09 |
52w Low $0.280 |
P/E - |
EPS -0.42 |
ZLD released this announcement to the ASX on 22 October 2020, 8:13. The announcement is not marked as price sensitive, and is 17 page(s) in length and 1.95MB in size.
You can view all announcements from ZLD and see how they appear on a price chart on the announcements page.
At the date of this announcement, ZLD was 0.010% short sold according to ASIC data. It was ranked the 520th most shorted stock on the ASX. It is now ranked as the 508th most shorted stock on the ASX with 0.019% of total shares short sold as of the latest reported data (08 August 2024).
| Other Recent Announcements from ZLD | |
|---|---|
| Amendment to ASX announcement - Zelira's diabetic nerve pai | 8 June 2023, 9:47 |
| Initial Director's Interest Notice | 1 June 2023, 15:29 |
| Final Director's Interest Notice | 1 June 2023, 15:27 |
| Proposed issue of securities - ZLD | 31 May 2023, 16:22 |
| Zelira Non-Executive Director Appointed | 31 May 2023, 16:14 |
| Updated Investor Presentation - Non-Deal Roadshow | 22 October 2020, 8:13 |
| Cleansing Notice and Appendix 2A | 16 October 2020, 17:04 |
You must be logged in to post a reply.
Zelira Therapeutics 